Counterweight Ventures’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $837K | Hold |
93,384
| – | – | 0.55% | 46 |
|
|
2025
Q1 | $700K | Hold |
93,384
| – | – | 0.5% | 46 |
|
|
2024
Q4 | $702K | Hold |
93,384
| – | – | 0.5% | 46 |
|
|
2024
Q3 | $710K | Buy |
93,384
+79,884
| +592% | +$607K | 0.5% | 47 |
|
|
2024
Q2 | $83.4K | Hold |
13,500
| – | – | 0.06% | 63 |
|
|
2024
Q1 | $68.6K | Hold |
13,500
| – | – | 0.06% | 64 |
|
|
2023
Q4 | $80.9K | Buy |
+13,500
| New | +$80.9K | 0.07% | 61 |
|